SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-20-019432
Filing Date
2020-04-29
Accepted
2020-04-29 08:00:46
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 2019 FORM 10-K/A - APRIL 2020 alna-10ka_20191231.htm 10-K/A 527894
2 EX-31.1 alna-ex311_7.htm EX-31.1 8750
3 EX-31.2 alna-ex312_6.htm EX-31.2 6941
  Complete submission text file 0001564590-20-019432.txt   544639
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38268 | Film No.: 20827467
SIC: 2836 Biological Products, (No Diagnostic Substances)